Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans.

Fourteen patients with severe viral illnesses were given intravenous infusions of a modified interferon inducer, polyriboinosinic-polyribocytidylic acid-poly-L-lysine complexed with carboxymethylcellulose [poly)I:C.LC)], during a phase 1 clinical trial. The first eight patients received 0.15 to 0.30...

Popoln opis

Bibliografske podrobnosti

izdano v:	Infect Immun
Principais autores:	Champney, K J, Levine, D P, Levy, H B, Lerner, A M
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1979
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC414523/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/500189/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.25.3.831-837.1979
Oznake:	Označite Brez oznak, prvi označite!